Oramed Pharmaceuticals
ORMP
ORMP
59 hedge funds and large institutions have $15.2M invested in Oramed Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $15.4M → $15.2M (-$115K)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
Holders
59
Holding in Top 10
1
Calls
$54K
Puts
$10K
Top Buyers
| 1 | +$1.3M | |
| 2 | +$824K | |
| 3 | +$348K | |
| 4 |
Renaissance Technologies
New York
|
+$279K |
| 5 |
Millennium Management
New York
|
+$50K |
Top Sellers
| 1 | -$562K | |
| 2 | -$292K | |
| 3 | -$226K | |
| 4 |
D.E. Shaw & Co
New York
|
-$82.1K |
| 5 |
Jane Street
New York
|
-$78K |